December 03, 2025

New credential elevates GI nutrition collaboration

To earn credential, dietitians must complete at least 2,000 hours of GI-focused practice and pass a specialty exam.

Conexiant

December 02, 2025

Evaluating the benefit-risk profile of upadacitinib in IBD

Across multiple IBD trials, “upadacitinib consistently outperforms placebo with a generally favorable safety profile across diverse patient subgroups."

Conexiant

December 02, 2025

Mediterranean diet beats traditional dietary advice in IBS

Researchers say the diet could serve as a first-line dietary option for people with IBS.

Conexiant

November 25, 2025

AGA unveils new clinical practice guideline for Crohn's disease

Of the 16 recommendations, the panel rated one as “strong,” nine as “conditional,” and six as “knowledge gaps.”

Conexiant

November 18, 2025

Plozasiran Wins FDA Nod for FCS

Arrowhead’s small interfering RNA therapy reduced triglycerides and lowered pancreatitis risk in the phase 3 PALISADE trial, providing a quarterly self-administered option for patients with familial chylomicronemia syndrome.

Conexiant

November 17, 2025

‘Patent Dance’ Delays Biosimilars Despite FDA Shift

The FDA moves to speed biosimilar approvals, but rising patent barriers may still delay lower-cost alternatives.

Conexiant

November 12, 2025

Radiation Training Levels May Influence Safety Culture

Researchers examine how radiation knowledge shapes health care safety attitudes.

Conexiant

November 10, 2025

Gastric microbiome shifts track H pylori virulence

Pathogenic bacterial genotypes correlate with distinct microbial communities; overall α-diversity is unchanged, but virulent strains show greater diversity within subgroups as atrophy progresses

Conexiant

November 06, 2025

Microbiome: COVID-19's Hidden Factor?

Pre-pandemic microbiome composition influences severe disease outcomes years later in a population study. 

Conexiant